Kimberly Loo
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 8
-
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 1
- Co-authors
- Adil Daud (10 shared papers)Alain P. Algazi (8 shared papers)Katy K. Tsai (8 shared papers)Adi Nosrati (5 shared papers)Matthew F. Krummel (4 shared papers)Michael D. Rosenblum (5 shared papers)Jimmy J. Hwang (4 shared papers)Michael Alvarado (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Pigment Cell & Melanoma Research (2 papers)Journal of Clinical Investigation (1 paper)Frontiers in Immunology (1 paper)Magnetic Resonance in Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandAustria
In The Last Decade
Kimberly Loo
17 papers receiving 661 citations
Kimberly Loo's Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 478
- Immunology 307
- Pulmonary and Respiratory Medicine 75
- Cancer Research 35
- Pathology and Forensic Medicine 36
Countries citing papers authored by Kimberly Loo
This map shows the geographic impact of Kimberly Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Loo more than expected).
Fields of papers citing papers by Kimberly Loo
This network shows the impact of papers produced by Kimberly Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Loo. The network helps show where Kimberly Loo may publish in the future.
Co-authors
The 25 scholars most cited alongside Kimberly Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma Hit paper breakdown → | 2016 | 396 |
| 2 | 2017 | 99 | |
| 3 | 2017 | 56 | |
| 4 | 2009 | 30 | |
| 5 | 2016 | 21 | |
| 6 | 2016 | 15 | |
| 7 | 2022 | 13 | |
| 8 | 2015 | 11 | |
| 9 | 2017 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 4 | |
| 13 | 2016 | 2 | |
| 14 | 2016 | 2 | |
| 15 | 2021 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2015 | 1 |
About Kimberly Loo
Kimberly Loo is a scholar working on Oncology, Immunology, Molecular Biology, Economics and Econometrics and Biomedical Engineering, having authored 17 papers that have together received 668 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (5 papers), Melanoma and MAPK Pathways (3 papers), Economic and Financial Impacts of Cancer (2 papers), Immune cells in cancer (1 paper), Spine and Intervertebral Disc Pathology (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (478 citations), Immunology (307 citations), Pulmonary and Respiratory Medicine (75 citations), Cancer Research (35 citations) and Pathology and Forensic Medicine (36 citations). Kimberly Loo has collaborated with scholars based in United States, Switzerland and Austria. Frequent co-authors include Adil Daud, Alain P. Algazi, Katy K. Tsai, Adi Nosrati, Matthew F. Krummel, Michael D. Rosenblum, Jimmy J. Hwang, Michael Alvarado, Mariela Pauli and Priscila Muñoz Sandoval. Their work appears in journals such as Journal of Clinical Oncology, Pigment Cell & Melanoma Research, Journal of Clinical Investigation, Frontiers in Immunology and Magnetic Resonance in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.